Commercial Reasonableness

Independent evaluation of whether a proposed transaction, investment, or capital structure is economically and commercially supportable.

This analysis is performed where valuation alone is insufficient, and decision-making requires assessment of execution feasibility, capital constraints, and real-world conditions.

Commercial reasonableness may include evaluation of:

• Transaction pricing relative to underlying economics 
• Cash flow sustainability and downside exposure 
• Capital structure and financing assumptions 
• Allocation of risk among stakeholders 
• Timing and execution constraints 

Commercial reasonableness is typically required in situations involving:

• Related-party or non-arm’s-length transactions 
• Cross-border investments and capital deployment 
• Infrastructure and asset-intensive investments 
• Internal approvals, board review, or audit scrutiny 

Project feasibility is evaluated as one component of commercial reasonableness.

This includes assessment of whether:

• Projected performance assumptions are achievable 
• Cost, schedule, and capital requirements are realistic 
• Operational and market conditions support the proposed outcome 

Feasibility is considered within the broader context of capital execution and economic viability, not as a standalone study.

Analysis is structured to reflect actual operating and capital conditions, rather than theoretical projections.

Focus is placed on:

• Interaction between valuation and capital structure 
• Sensitivity to downside scenarios 
• Practical execution constraints affecting outcomes 

The objective is to determine whether a transaction or investment is defensible under real-world conditions.

Commercial reasonableness is provided as an independent, fee-based advisory service.

This practice does not act as a broker or intermediary, and does not rely on contingent or success-based compensation.

Assignments are accepted selectively, particularly where:

• Capital commitments are significant 
• Independent judgment is required 
• Outcomes must withstand scrutiny from investors, auditors, or regulators 

• Corporate management and boards 
• CPA and accounting advisory firms 
• Legal counsel (transaction and regulatory) 
• Investors and sponsors 
• Cross-border participants and strategic capital providers